Welcome
Welcome to the Wagner lab!
The group is dedicated to the development, and preclinical as well as clinical testing, of HIV candidate vaccines. According to the necessity of rational vaccine design the group is focussing on various aspects of epidemiology, viral pathogenesis and morphogenesis, HIV replication, and vaccine manufacturing, including preclinical and clinical monitoring of antigen-specific B- and T-cell responses. The group is fully financed by national and international grants such as the Bavarian Research Foundation (Bayerische Forschungsstiftung), the German Ministry of Education and Research (BMBF), the European Union and the Bill & Melinda Gates Foundation.
- startbild
News
2nd HIVacToGC Project partner meeting in Regensburg
On 20th July the 2nd HIVacToGC Project partner meeting will take place at the Institute of Medical Microbiology and Hygiene of the University of Regensburg. We are very happy to welcome or Project partner representatives and... > more
Towards a Therapeutic HPV Vaccine - Highlight of biomedical research, University Hospital, Regensburg, June 2023
Regensburg, 2023-06-07: Our recently published study, proofing suitability of a therapeutic HPV vaccine for the treatment of HPV-induced cancer in C57B/l mice , was selected by the UKRs Research Coordination (Forschungsrat) as... > more
COVID-19-Immunität im Landkreis Tirschenreuth
Erstes Zwischenfazit zur Studie „Prospektive COVID-19-Kohorte Tirschenreuth“ (TiKoCo19) > more
Neues Projekt gestartet: HIVacToGC
Regensburg, 2021-03-30:Im März ist das mit Bundesmitteln geförderte, interdisziplinäre Forschungsprojekt "HIVacToGC" gestartet, das neue Ansätze zur Prävention und Therapie von HIV-Infektionen erforscht; unter der... > more
Alexandra Hauser received New Investigator Award at HIVR4P // Virtual conference
Alexandra Hauser, a PhD student in the lab, has been selected as recipient of the "New Investigator Award" at the HIV Research for Prevention (HIVR4P) conference. The biannual HIVR4P meeting, that is organized the... > more